Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vascular Access Port”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Not applicableStudy completedNCT05209828
What this trial is testing

Post-market Clinical Follow-up of Pfmmedical Ports

Who this might be right for
Vascular Access PortPatient Satisfaction
pfm medical gmbh 149
Post-approval studies (Phase 4)Not Yet RecruitingNCT07404345
What this trial is testing

Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)

Who this might be right for
Hemodialysis Access FailureKidney Disease, End-StageHemodialysis Catheter
Hospital Civil de Guadalajara 54
Not applicableStudy completedNCT00484848
What this trial is testing

Functional Evaluation of Two Types of Totally Implanted Venous Ports

Who this might be right for
Hematologic Disease
Universitaire Ziekenhuizen KU Leuven 200
Post-approval studies (Phase 4)UnknownNCT01336439
What this trial is testing

Effects of Botulinum Toxin Type A(Meditoxin®) on Sleep Bruxism

Who this might be right for
Sleep Bruxism
Yonsei University 24
Early research (Phase 1)Study completedNCT00614029
What this trial is testing

Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System

Who this might be right for
PharmacokineticsBioequivalence
Zogenix, Inc. 54
Early research (Phase 1)Study completedNCT03232983
What this trial is testing

LY900014 Formulation at Different Injection Sites in Healthy Participants

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 28
Large-scale testing (Phase 3)Study completedNCT00290342
What this trial is testing

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 458
Not applicableUnknownNCT04577950
What this trial is testing

A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Centre Hospitalier Universitaire Vaudois 120
Post-approval studies (Phase 4)Ended earlyNCT03523091
What this trial is testing

OnabotulinumtoxinA Bladder Injection Study

Who this might be right for
Overactive BladderOveractive Bladder SyndromeUrinary Urgency+3 more
Corewell Health East 6
Not applicableUnknownNCT03484754
What this trial is testing

Infiltrations of OnaBotulinum Toxin A in Resistant Depression: Comparison of Two Facial Injection Sites.

Who this might be right for
Major Depression
Centre Hospitalier Esquirol 58
Early research (Phase 1)Study completedNCT04050670
What this trial is testing

Tirzepatide at Different Injection Sites in Participants With Different Body Sizes

Who this might be right for
Healthy
Eli Lilly and Company 54
Early research (Phase 1)Study completedNCT06577428
What this trial is testing

RAY1225 at Different Injection Sites in Participants With Different Body Sizes

Who this might be right for
Healthy
Guangdong Raynovent Biotech Co., Ltd 48
Not applicableStudy completedNCT01767324
What this trial is testing

Site Selection for Intracutaneous Saline Delivery

Who this might be right for
Intracutaneous Drug Delivery
FluGen Inc 12
Early research (Phase 1)Looking for participantsNCT06548906
What this trial is testing

GZR4 Injection at Different Injection Sites

Who this might be right for
Healthy Subjects
Gan and Lee Pharmaceuticals, USA 24
Early research (Phase 1)Study completedNCT05615532
What this trial is testing

A Relative Bioavailability Study of LY3209590 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 168
Testing effectiveness (Phase 2)Study completedNCT02710526
What this trial is testing

Phase II Pharmacokinetics Study of CAM2038

Who this might be right for
Opioid Use DisorderChronic Pain
Braeburn Pharmaceuticals 66
Early research (Phase 1)Not Yet RecruitingNCT07400679
What this trial is testing

Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity

Who this might be right for
OverweightObesityHealthy
Pfizer 54
Not applicableWithdrawnNCT01584193
What this trial is testing

Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection for Venous Access Port Implantation

Who this might be right for
Vascular Surgical Procedures
University of Lausanne Hospitals
Testing effectiveness (Phase 2)Study completedNCT00607880
What this trial is testing

Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificVascular Access Device Complications
Mayo Clinic 100
Not applicableEnded earlyNCT02069860
What this trial is testing

BONE ANCHORED PORT for Hemodialysis Treatment

Who this might be right for
End-Stage Renal Disease Requiring HaemodialysisHemodialysis Access Failure (Disorder)
Cendres+Métaux 6
Load More Results